DSM.AS - DSM-Firmenich AG
Chart Events
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 114.00 |
| Open | 114.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 113.40 - 114.50 |
| 52 Week Range | 105.80 - 164.00 |
| Volume | |
| Avg. Volume | 360,622 |
| Market Cap | 762.729M |
| Beta (5Y Monthly) | 0.72 |
| PE Ratio (TTM) | 18.25 |
| EPS (TTM) | 6.24 |
| Earnings Date | Aug 02, 2023 |
| Forward Dividend & Yield | 2.63 (2.31%) |
| Ex-Dividend Date | Aug 04, 2022 |
| 1y Target Est | 147.90 |
Fair Value
Related Research
Simply Wall St.Analysts Just Made A Massive Upgrade To Their Koninklijke DSM N.V. (AMS:DSM) Forecasts
Celebrations may be in order for Koninklijke DSM N.V. ( AMS:DSM ) shareholders, with the analysts delivering a...
- Simply Wall St.
With 57% institutional ownership, Koninklijke DSM N.V. (AMS:DSM) is a favorite amongst the big guns
Key Insights Given the large stake in the stock by institutions, Koninklijke DSM's stock price might be vulnerable to...
PR NewswireFINAL RESULTS OF THE EXCHANGE OFFER: 96.1% OF DSM ORDINARY SHARES TENDERED
9.6% of the DSM Ordinary Shares have been tendered in the Exchange Offer during the Post-Closing Acceptance Period
- PR Newswire
DSM - delivery of shares
Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.
- PR Newswire
EXCHANGE OFFER DECLARED UNCONDITIONAL
DSM and Firmenich boards very happy to announce that the Company hereby declares the Exchange Offer unconditional
PR NewswireSUPPLEMENT TO THE OFFERING CIRCULAR DATED 22 NOVEMBER 2022 PUBLISHED
As indicated in our prior press releases of 31 March 2023 and 4 April 2023, DSM and Firmenich published today a supplement to the offering circular dated 22 November 2022. This supplement can be found on the transaction website: https://www.creator-innovator.com/.
PR NewswireDSM AND FIRMENICH HAVE OBTAINED ALL COMPETITION CLEARANCES
DSM and Firmenich jointly announce that they have obtained competition clearance from the Competition Commission of India (CCI) on 3 April 2023.1 DSM and Firmenich now have competition clearance in all required jurisdictions, as a result of which the Transaction Condition relating to the competition clearances has now been satisfied.
- PR Newswire
DSM completes sale of Engineering Materials business
Royal DSM, a global purpose-led science-based company, today announces the completion of the sale of its Engineering Materials business to Advent International and LANXESS for an Enterprise Value of €3.85 billion. The agreement was initially announced on 31 May 2022.
- PR Newswire
Acceptance Period Extended Pending Indian Competition Clearance Until No Later Than 12 May 2023
On 23 January 2023, the acceptance period during which DSM Shareholders can tender their DSM Ordinary Shares into the Exchange Offer was extended as not all competition clearances would have been obtained by 31 January 2023 (the initial expiry date of the acceptance period). On 23 February 2023, we announced that we obtained nine out of the ten required competition clearances (including those in the European Union and China), and that the last competition clearance that is pending is the Indian
- Simply Wall St.
Koninklijke DSM Full Year 2022 Earnings: EPS Beats Expectations
Koninklijke DSM ( AMS:DSM ) Full Year 2022 Results Key Financial Results Revenue: €8.39b (up 15% from FY 2021). Net...
- PR Newswire
DSM publishes 2022 Integrated Annual Report
Royal DSM, a global purpose-led, performance-driven leader in Health, Nutrition & Bioscience, today announces the publication of its 2022 Integrated Annual Report (IAR).
- Simply Wall St.
Koninklijke DSM (AMS:DSM) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...
- PR Newswire
DSM and Firmenich Have Obtained Competition Clearance from the European Commission
DSM and Firmenich jointly announce that they have obtained the unconditional competition clearance from the European Commission on 22 February 2023. This follows the unconditional competition clearance of China's State Administration for Market Regulation (SAMR) received on 16 February 2023. Consequently, competition clearance has been obtained in nine out of the ten jurisdictions required to satisfy the offer condition relating to competition clearances.1
- PR Newswire
DSM shareholders approve DSM-Firmenich merger at Extraordinary General Meeting
Royal DSM, a global purpose-led science-based company, today held an Extraordinary General Meeting of Shareholders (EGM). The DSM Shareholders approved the proposed merger between DSM and Firmenich International SA (Firmenich) and voted in favour of all related resolutions as set out in the notice of the EGM.
- PR Newswire
Acceptance Period For Exchange Offer Extended Pending Competition Clearances
The acceptance period during which DSM Shareholders can tender their DSM Ordinary Shares into the Exchange Offer that launched on 22 November 2022, which acceptance period was to expire on 31 January 2023, will be extended. The reason for this extension is that not all competition clearances will have been obtained by 31 January 2023.
- Simply Wall St.
Those who invested in Koninklijke DSM (AMS:DSM) five years ago are up 58%
When we invest, we're generally looking for stocks that outperform the market average. And the truth is, you can make...
- Simply Wall St.
Koninklijke DSM N.V.'s (AMS:DSM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
It is hard to get excited after looking at Koninklijke DSM's (AMS:DSM) recent performance, when its stock has declined...
- Simply Wall St.
Here's Why Koninklijke DSM (AMS:DSM) Has Caught The Eye Of Investors
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
- PR Newswire
DSM starts construction of large scale production facility for its novel methane-reducing feed additive for ruminants, Bovaer® in Dalry, Scotland
Royal DSM, a global purpose-led science-based company active in Health, Nutrition and Bioscience, today began construction of a new manufacturing facility at its site in Dalry, Scotland. The plant will significantly increase global production of Bovaer®, DSM's unique methane-reducing feed additive for cattle. In an official groundbreaking ceremony attended by the First Minister of Scotland, Nicola Sturgeon, and Dimitri de Vreeze, Co-CEO of DSM, the company marked the next step in its plan to use
- PR Newswire
PUBLICATION OF THE OFFERING CIRCULAR IN RELATION TO THE MERGER BETWEEN DSM AND FIRMENICH AND THE LISTING OF DSM-FIRMENICH ON EURONEXT AMSTERDAM
DSM and Firmenich jointly announce the launch of the Exchange Offer as part of their merger of equals to create DSM-Firmenich. The two companies will hold a joint webcast today for analysts and investors to provide an update on the progress made so far as well as a trading update for Firmenich for the period July to September 2022.
- Simply Wall St.
With 52% ownership of the shares, Koninklijke DSM N.V. (AMS:DSM) is heavily dominated by institutional owners
To get a sense of who is truly in control of Koninklijke DSM N.V. ( AMS:DSM ), it is important to understand the...
- PR Newswire
Science Based Targets initiative validates DSM's ambition to reduce direct greenhouse gas emissions as 1.5°C aligned
Royal DSM, a global purpose-led science-based company, confirms that its target to cut scope 1 and 2 greenhouse gas (GHG) emissions has been determined to be in line with the latest climate science and in keeping global warming to no more than 1.5°C by the Science Based Targets initiative (SBTi).
- Simply Wall St.
Estimating The Fair Value Of Koninklijke DSM N.V. (AMS:DSM)
Today we will run through one way of estimating the intrinsic value of Koninklijke DSM N.V. ( AMS:DSM ) by taking the...